Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Abiraterone acetate is a type of hormone therapy, classified as an “adrenal inhibitor". It is indicated for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel.
Adverse effect: Hypertension: Abiraterone may cause an increase in blood pressure, Urinary tract infection: Cloudy or smelly urine, pain or discomfort when passing urine, Diarrhea : Drink plenty of fluids if you have diarrhea at least 2 litres (about 3 pints) a day.
Related Journals of Abiraterone Acetate